A Rare Occurrence of Pulmonary Alveolar Proteinosis after Lung Transplantation

被引:11
作者
Albores, Jeffrey [1 ]
Seki, Atsuko [2 ]
Fishbein, Michael C. [2 ]
Abtin, Fereidoun [3 ]
Lynch, Joseph P., III [1 ]
Wang, Tisha [1 ]
Weigt, S. Samuel [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA
关键词
lung transplantation; pulmonary alveolar proteinosis; interstitial lung disease; immunosuppression; COLONY-STIMULATING FACTOR; PATHOGENESIS; DISEASE;
D O I
10.1055/s-0033-1348472
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We present a case of pulmonary alveolar proteinosis (PAP) initially diagnosed 28-months after left single-lung transplantation for idiopathic pulmonary fibrosis. The diagnosis was based upon the presence of periodic acid-Schiff (PAS)-positive and surfactant immunostain-positive acellular lipoproteinaceous material within alveoli seen on transbronchial biopsy as well as in bronchoalveolar lavage fluid. The patient eventually also displayed a characteristic "crazy paving" pattern on radiographic imaging. Granulocyte macrophage-colony stimulating factor antibodies were negative, consistent with secondary PAP. PAP is a rare interstitial lung disease with only a few reported cases occurring after lung transplantation. The etiology is thought to be related to a defect in macrophage function caused by immunosuppression. Reduced immunosuppression has been associated with stabilization, but not reversal, of the condition in the case reported here. PAP is an exceptionally rare cause of dyspnea and radiographic infiltrates after lung transplantation and may be related to toxicity of immune-suppressive medications.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 25 条
[1]  
Bag R., 2003, Journal of Heart and Lung Transplantation, V22, pS139, DOI 10.1016/S1053-2498(02)00898-7
[2]  
BEDROSSIAN CWM, 1980, HUM PATHOL, V11, P527
[3]   Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis [J].
Bonfield, TL ;
Russell, D ;
Burgess, S ;
Malur, A ;
Kavuru, MS ;
Thomassen, MJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (04) :481-486
[4]   The molecular basis of pulmonary alveolar proteinosis [J].
Carey, Brenna ;
Trapnell, Bruce C. .
CLINICAL IMMUNOLOGY, 2010, 135 (02) :223-235
[5]   EXOGENOUS SURFACTANT FUNCTION IN VERY PRETERM LAMBS WITH AND WITHOUT FETAL CORTICOSTEROID TREATMENT [J].
CHEN, CM ;
IKEGAMI, M ;
UEDA, T ;
POLK, DH ;
JOBE, AH .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 78 (03) :955-960
[6]   The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report-2012 [J].
Christie, Jason D. ;
Edwards, Leah B. ;
Kucheryavaya, Anna Y. ;
Benden, Christian ;
Dipchand, Anne I. ;
Dobbels, Fabienne ;
Kirk, Richard ;
Rahmel, Axel O. ;
Stehlik, Josef ;
Hertz, Marshall I. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (10) :1073-1086
[7]   SECONDARY ALVEOLAR PROTEINOSIS IS A REVERSIBLE CAUSE OF RESPIRATORY-FAILURE IN LEUKEMIC PATIENTS [J].
CORDONNIER, C ;
FLEURYFEITH, J ;
ESCUDIER, E ;
ATASSI, K ;
BERNAUDIN, JF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :788-794
[8]   Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation [J].
Gal, AA ;
Bryan, JA ;
Kanter, KR ;
Lawrence, EC .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (01) :135-138
[9]   The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis [J].
Ho, VT ;
Mirza, NQ ;
del Junco, D ;
Okamura, T ;
Przepiorka, D .
BONE MARROW TRANSPLANTATION, 2003, 32 (08) :771-775
[10]   Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management [J].
Huizar, Isham ;
Kavuru, Mani S. .
CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (05) :491-498